Exhibit 10.2
SECOND amendment to employment agreement
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”), dated as of July 10, 2023, between EyePoint Pharmaceuticals, Inc. (the “Company”), and Jay S. Duker, M.D. (“Employee”).
W I T N E S S E T H
WHEREAS, the Company and Employee have previously entered into that certain Amended and Restated Employment Agreement, effective as of November 1, 2021, as amended by that certain First Amendment to Employment Agreement, effective as of January 3, 2023 (collectively, the “Employment Agreement”);
WHEREAS, the Company and Employee desire to enter into this Second Amendment to modify certain provisions of the Employment Agreement.
NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the parties hereto agree as follows:
MACROBUTTON DocID \\4146-9655-7384 v6
MACROBUTTON DocID \\4146-9655-7384 v6
[Signature Page Follows]
MACROBUTTON DocID \\4146-9655-7384 v6
IN WITNESS WHEREOF, the parties have executed this Amendment on the date first set forth above.
EYEPOINT PHARMACEUTICALS, INC.
By_/s/ Jennifer Leonard__________________
Name: Jennifer Leonard
Title: Chief People Officer & SVP IT
/s/ Jay Duker____________________________
Jay S. Duker, M.D.
MACROBUTTON DocID \\4146-9655-7384 v6